Development and optimization of targeted radionuclide tumor therapy using folate-based radiopharmaceuticals

ETHZ users
Author
Date
2013Type
- Doctoral Thesis
ETH Bibliography
yes
Altmetrics
Permanent link
https://doi.org/10.3929/ethz-a-010077490Publication status
publishedExternal links
Search print copy at ETH Library
Publisher
ETH-ZürichSubject
KREBSTHERAPIE + TUMORTHERAPIE (MEDIZIN); RADIOPHARMAKOLOGIE + RADIOPHARMAKA; VITAMIN-BC, FOLSÄUREN (BIOCHEMIE); NUKLEARMEDIZIN + RADIOMEDIZIN; ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); THERAPEUTISCHE PHARMAKOLOGIE, VERABREICHUNG VON ARZNEIMITTELN, CHEMOTHERAPIE, KLINISCHE PHARMAKOLOGIE; KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE); NIEREN (ANATOMIE UND PHYSIOLOGIE); CANCER TREATMENT + TUMOUR TREATMENT (MEDICINE); RADIOPHARMACOLOGY + RADIOPHARMACEUTICALS; VITAMIN BC, FOLIC ACIDS (BIOCHEMISTRY); MEDICAL RADIOLOGY + NUCLEAR MEDICINE; TARGETED DRUGS (PHARMACOLOGY); CLINICAL PHARMACOLOGY, THERAPEUTICAL PHARMACOLOGY, CHEMOTHERAPY, MEDICATION, ADMINISTRATION OF DRUGS; CARCINOSTATICS + ANTINEOPLASTICS + ONCOSTATICS + CANCER REMEDIES (PHARMACY); KIDNEYS (ANATOMY AND PHYSIOLOGY)Organisational unit
02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.03688 - Schibli, Roger / Schibli, Roger
Notes
Diss., Eidgenössische Technische Hochschule ETH Zürich, Nr. 21545, 2013.More
Show all metadata
ETH Bibliography
yes
Altmetrics